Regencell Bioscience Holdings Limited
Every calculator, already run for RGC
Open the full toolkit →You have the numbers on RGC. Get the argument.
A written report on which of these readings actually decide the outcome for Regencell Bioscience Holdings Limited, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Ownership & short interest
Insider Trading Activity for RGC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
RGC — frequently asked
Is RGC a buy right now?
Wall Street's consensus rating on Regencell Bioscience Holdings Limited is none. Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
When is RGC's next earnings date?
Regencell Bioscience Holdings Limited is next scheduled to report earnings around Oct 28, 2026. A full RGC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
Compare Regencell Bioscience Holdings Limited against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Regencell Bioscience Holdings Limited
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full RGC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Regencell Bioscience Holdings Limited, in minutes. 3 free reports included with every account — no credit card required.